Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3).

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Immunopharmacology

• Publication date

  1990-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0162-3109(90)90005-YPMID 1699910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological effects of cyclosporin A: A new antilymphocytic agent

  2005cited by this paper
• Inhibition of histamine release from human lung and rat peritoneal mast cells by cyclosporin-A

  1990cited by this paper
• Biochemical characterization of the inhibitory effect of CsA on cytolytic T lymphocyte effector functions.

  1989cited by this paper
• Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin

  1989cited by this paper
• Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.

  1989cited by this paper
• A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

  1989cited by this paper
• Identification of cyclophilin as the erythrocyte ciclosporin-binding protein.

  1988cited by this paper
• Effect of cyclosporin A on rat mucosal mast cells and the associated protease RMCPII.

  1988cited by this paper
• Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design.

  1987cited by this paper
• Calmodulin antagonism: a pharmacological approach for the inhibition of mediator release from mast cells.

  1987cited by this paper
• Mechanism of signal transduction in mast cells and basophils: studies with RBL-2H3 cells.

  1987cited by this paper
• Possible role of calmodulin in the control of histamine release from human basophil leukocytes.

  1986cited by this paper
• Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.

  1986cited by this paper
• Does the binding of cyclosporine to calmodulin result in immunosuppression?

  1986cited by this paper
• [The role of protein kinase C in cell surface signal transduction and tumor promotion].

  1986cited by this paper
• Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.

  1986cited by this paper
• Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.

  1985cited by this paper
• Calmodulin in mast cells and its role in histamine secretion

  1985cited by this paper
• Inhibitory Effect of Cyclosporin A on Histamine Release from Human Leukocytes and Rat Mast Cells

  1985cited by this paper
• Activation of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and gamma-interferon genes.

  1985cited by this paper
• Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.

  1984cited by this paper
• CYCLOSPORINE DOES NOT PREVENT CYTOPLASMIC CALCIUM CHANGES ASSOCIATED WITH LYMPHOCYTE ACTIVATION

  1984cited by this paper
• Effect of cyclosporin A and inhibitors of arachidonic acid metabolism on blood flow and cyclo‐oxygenase products in rat skin allografts

  1984cited by this paper
• Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

  1984cited by this paper
• Synergistic action of protein kinase C and calcium for histamine release from rat peritoneal mast cells.

  1984cited by this paper
• The role of protein kinase C in cell surface signal transduction and tumour promotion

  1984cited by this paper
• Inositol trisphosphate and diacylglycerol as second messengers.

  1984cited by this paper
• Cyclosporin A (Sandimmun®) modulates the Ca2+ uptake of mitogen-stimulated lymphocytes

  1984cited by this paper
• Restoration of Ca2+ influx and degranulation capacity of variant RBL-2H3 cells upon implantation of isolated cromolyn binding protein.

  1983cited by this paper
• Treatment of intraocular inflammatory disease with cyclosporin A.

  1983cited by this paper
• Selective suppression of an early step in human B cell activation by cyclosporin A

  1983cited by this paper
• Cyclosporine in human bone marrow transplantation. Serum concentration, graft-versus-host disease, and nephrotoxicity.

  1983cited by this paper
• BLOOD FLOW, HISTAMINE CONTENT AND HISTIDINE DECARBOXYLASE ACTIVITY IN RAT SKIN GRAFTS AND THEIR MODIFICATION BY CYCLOSPORIN‐A

  1982cited by this paper
• On the calcium receptor activating exocytosis: inhibitory effects of calmodulin‐interacting drugs on rat mast cells.

  1982cited by this paper
• Effects of cyclosporin A on the immune system of the mouse. I. Evidence for a direct selective effect of cyclosporin A on B cells responding to anti‐immunoglobulin antibodies

  1982cited by this paper
• Biopharmacological Assessment of Calmodulin Function: Utility of Calmodulin Antagonists

  1982cited by this paper
• Cyclosporin A – Usefulness, Risks and Mechanism of Action

  1982cited by this paper
• The effects of substance P on histamine and 5‐hydroxytryptamine release in the rat

  1982cited by this paper
• Stimulus-secretion coupling in rat basophilic leukemia cells.

  1981cited by this paper
• Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

  1981cited by this paper
• Cyclosporin A in cadaveric organ transplantation.

  1981cited by this paper
• Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response.

  1981cited by this paper
• Inhibition of IgE-mediated histamine release from rat basophilic leukemia cells and rat mast cells by inhibitors of transmethylation.

  1981cited by this paper
• IgE‐induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones

  1981cited by this paper
• Cyclosporin A.

  1981cited by this paper
• The purification of human basophils.

  1980cited by this paper
• Selective inhibitors of Ca2+-binding modulator of phosphodiesterase produce vascular relaxation and inhibit actin-myosin interaction.

  1979cited by this paper
• Slow reacting substances: comparison of some properties of human lung SRS-A and two distinct fractions from ionophore-induced rat mononuclear cell SRS.

  1979cited by this paper
• Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function.

  1979cited by this paper
• Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes by the calcium ionophore A23187.

  1976cited by this paper
• Stimulation and Inhibition of Histamine Release from Isolated Rat Mast Cells

  1975cited by this paper
• Mechanism of action of concanavalin A on human basophils.

  1975cited by this paper
• Mechanism of Action of Concanvalin A on Human Basophils

  1975cited by this paper
• Stimulation and inhibition of histamine release from isolated rat mast cells. Dual effects of the ionophore A23187.

  1975cited by this paper
• THE INTERACTION OF IgE WITH RAT BASOPHILIC LEUKEMIA CELLS

  1974cited by this paper
• Calcium Ionophores and Movement of Calcium Ions following the Physiological Stimulus to a Secretory Process

  1973cited by this paper
• Basophilic leukaemia in the albino rat and a demonstration of the basopoietin.

  1973cited by this paper

• Sphingosine Kinase-1-Dependent and -Independent Inhibitory Effects of Zanthoxyli Fructus to Attenuate the Activation of Mucosal Mast Cells and Ameliorate Food Allergies in Mice

  2012cites this paper
• Effect of cyclosporin and tacrolimus (FK506) on the antigen-induced mediator release, membrane potential and 86Rb+/K+ and Ca2+ fluxes in the RBL-2H3 cell line.

  2006cites this paper
• Effect of cyclosporin-A on secretion from intact and permeabilised mast cells

  2005cites this paper
• Calcineurin antagonists differentially affect mediator secretion, p38 mitogen‐activated protein kinase and extracellular signal‐regulated kinases from immunologically activated human basophils

  2003cites this paper
• Allergen-induced bronchial eosinophilia in guinea-pigs is inhibited by both pre- and post-induction cyclosporin-A treatments.

  2000cites this paper
• Regulation of the function of eosinophils and basophils.

  1997cites this paper
• Anti-allergic activity of cyclosporin-A metabolites and their interaction with the parent compound and FK 506.

  1996cites this paper
• Effect of cyclosporin—A on histamine release from tracheal strips of sensitized guinea pigs

  1996cites this paper
• Lack of inhibition by cyclosporin in the Schultz-Dale reaction

  1995cites this paper
• Effect of cyclosporin analogues on histamine release from rat peritoneal mast cells and rat basophilic leukaemia cells

  1995cites this paper
• Release of eosinophil cationic protein (ECP) in anaphylactoid anaesthetic reactions in vivo and in vitro.

  1994cites this paper
• Treatment with cyclosporin A during sensitization with trimellitic anhydride attenuates the airway responses to allergen challenge three weeks later.

  1994cites this paper
• Release of esoinophil cationic protein (ECP) in anaphylactoid anaesthetic reactionsin vivo andin vitro

  1994cites this paper
• Comparative study of the anti-allergic and immunosuppressive activities of cyclosporin A and some of its analogues

  1992cites this paper
• Cyclosporine and FK506 inhibition of murine mast cell cytokine production.

  1992cites this paper
• Diet‐induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun®), cyclosporin H and FK506

  1992cites this paper
• Cell surface structures on human basophils and mast cells: biochemical and functional characterization.

  1992cites this paper
• Oral cyclosporine for severe chronic idiopathic urticaria and angioedema.

  1991cites this paper